Frankfurt
30.01.26 | 15:25
0,001 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.01. | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::LAPSE OF TERM SHEET IN RELATION TO THE PROPOSED ACQUISITION OF ELPIS BIOPHARMACEUTICALS PTE. LTD. | 1 | SGX Company Announcements | ||
| 13.11.25 | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::USE OF PROCEEDS FROM THE PLACEMENT | - | SGX Company Announcements | ||
| 03.11.25 | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::CLEARBRIDGE HEALTH COMMENCEMENT OF ADULT IMMUNE CELL BANKING BUSINESS | - | SGX Company Announcements | ||
| 06.10.25 | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::EXTENSION OF CONVERTIBLE BOND MATURITY DATE | 2 | SGX Company Announcements | ||
| CLEARBRIDGE HEALTH Aktie jetzt für 0€ handeln | |||||
| 20.08.25 | CLEARBRIDGE HEALTH LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF CHANGE IN INTEREST OF SUBSTANTIAL SHAREHOLDERS-YEE PINH JEREMY | 2 | SGX Company Announcements | ||
| 20.08.25 | CLEARBRIDGE HEALTH LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF CHANGE IN INTEREST OF SUBSTANTIAL SHAREHOLDERS-COOP INTERNATIONAL & BONVESTS HOLDINGS | 3 | SGX Company Announcements | ||
| 20.08.25 | CLEARBRIDGE HEALTH LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/UNITHOLDER(S)::DISCLOSURE OF CHANGE IN INTEREST OF SUBSTANTIAL SHAREHOLDERS-CHEN JOHNSON | 3 | SGX Company Announcements | ||
| 19.08.25 | Clearbridge Health raises $1.98m from 990 million placement shares | 2 | Singapore Business Review | ||
| 18.08.25 | CLEARBRIDGE HEALTH LIMITED: GENERAL ANNOUNCEMENT::CBH RAISED S$1.98 MILLION FROM PLACEMENT; BACKED BY HIGH-PROFILE INVESTORS TO FUEL STRATEGIC GROWTH | 2 | SGX Company Announcements | ||
| 18.08.25 | CLEARBRIDGE HEALTH LIMITED: PLACEMENTS::COMPLETION OF THE PROPOSED PLACEMENT CUM WARRANT ISSUE | 2 | SGX Company Announcements | ||
| 13.08.25 | CLEARBRIDGE HEALTH LIMITED: PLACEMENTS::RECEIPT OF LISTING AND QUOTATION NOTICE | - | SGX Company Announcements |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 41,550 | -2,92 % | DAX-Konzern Siemens Healthineers legt Zahlen vor | Siemens Healthineers startet solide ins neue Geschäftsjahr und bestätigt den Jahresausblick, wird aber vom schwachen Diagnostikgeschäft in China gebremst. Der DAX-Konzern Siemens Healthineers ist mit... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,460 | +0,47 % | Fresenius Medical Care: Ein genauer Blick in Richtung USA | Der Markt rechnet 2025 bei Fresenius Medical Care (FMC) mit einem Umsatz von 19,6 Millairden Euro und einem EBIT von rund 1,8 Milliarden Euro. Im Modell der Analysten von mwb research stehen 19,7 Milliarden... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,320 | 0,00 % | Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026 | Guides year-end 2026 health plan membership range of 290,000 to 296,000. Announces its expectation that consensus adjusted EBITDA of approximately $145 million in 2026 will be within its full-year... ► Artikel lesen | |
| FRESENIUS | 48,750 | -1,32 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 53,60 Euro auf "Overweight" belassen. Nach einem Unternehmenskontakt verglich Analyst David... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 28,940 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BILLIONTOONE | 83,51 | +0,99 % | BillionToOne, Inc.: BillionToOne Provides Guidance for 2026 | MENLO PARK, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| PROGYNY | 22,800 | 0,00 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| CONCENTRA GROUP | 22,940 | 0,00 % | Concentra Group Holdings Parent, Inc. - 8-K, Current Report | ||
| CARL ZEISS MEDITEC | 27,440 | -0,87 % | Brenntag, Carl Zeiss Meditec, Evonik, Hypoport, Porsche, TeamViewer: Neue Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| RXSIGHT | 7,940 | 0,00 % | RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer | ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 5,570 | 0,00 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Statement of CDIs on issue - AVR | ||
| PRIVIA HEALTH GROUP | 22,010 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,935 | 0,00 % | LifeStance Health Gr Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) | ||
| CERIBELL | 20,150 | 0,00 % | Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution | SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 2,600 | 0,00 % | The Oncology Institute reaffirms 2025 guidance, projects 2026 revenue |
CLEARBRIDGE HEALTH LIMITED gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,001 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CLEARBRIDGE HEALTH LIMITED finden Sie auf Wallstreet Online.